>1. FDA approval or near-approval of ATryn during 1H09, followed by a buyout/merger at a substantially better valuation than the current share price.
My worry now is even FDA approval can't save this company. The indication is too small and seem like no one except some of us here see GTCB beyond their cash can last.
What a disaster.
I hoped Cox can give me a sense of urgency and vision today, instead, he is in denial and still in hope for the best mode.
But can we blame him? I can't believe 25 cents after all these accomplishment. He probably are pissed too.